Existing Account?

For general enquiries, please contact Ms. Joy Chang
+886-2-2798-8329 Ext. 48 mbi2022@elitepco.com.tw

Scientific Programme

The symposium will comprise of excellent scientific programme on Oct. 29-30, including (1) keynote speeches from influential scientists worldwide, (2) PNIRSAsia-Pacific Sponsored Symposium, (3) state of the art symposia, and presentations from researchers and clinicians, (4) lectures of psychiatric researches and (5) virtual poster sessions. The symposium venue is to be announced.

 

 Programme Overview 

 

 Programme Details 

PK1. Plenary Keynote 1

Yeon-Ray Wen Neuromodulation in Chronic Pain Management: Not Only Modulate Pain, but Also Body And Mind 

PK2. Plenary Keynote 2

Neil Harrison | Inflammation-induced sickness and depression: Insights from human experimental challenge studies

PK3. Plenary Keynote 3

David Mischoulon | Placebo Effects: Blessing and Curse

 

S11. Long-COVID Session

S12. PNIRS Asia-Pacific Session

  • Keith W. Kelley, PhD (Chair)
  • Sarah J. Spencer, PhD (Chair) | Pain subtypes and the distinct and overlapping mechanisms behind them. 
  • Zhen Zheng, PhD | Pain phenotypes and their relevance to acupuncture analgesia.
  • Peter Grace, PhD | B cell regulation of neuropathic pain.
  • Naomi Eisenberger, PhD | Why does rejection hurt? Exploring the shared neural circuitry underlying physical and social pain. 

S13. Pain Treatment from Eastern to Western Methods Session

  • I-Han Hsiao MD, PhD (Chair) | Using novel techniques to investigate pain and depression 
  • Hsien-Yin Liao Ph.D., M.D. (Chair) | Clinical Efficacy and Immune Effects of Acupuncture in Patients with Comorbid Chronic Pain and Major Depression Disorder: A Double-Blinded, Randomized Controlled Crossover Study
  • Younbyoung Chae Ph.D., K.M.D. | Mind-body interaction of acupuncture actions in pain control

S21. Novel Treatment for Depression Session

  • David Mischoulon, MD, PhD (Chair) | Leveraging Placebo Effects and Mind-Body Phenomena in the Treatment of Depression
  • Cristina Cusin, MD | Neurobiological Underpinnings of Placebo Response in Major Depressive Disorder:  Methodology of a biomarker study using PET/MRI 
  • Lauren Fisher, PhD | Feasibility and Acceptability of Adapted Cognitive Behavioral Therapy for Depression after Traumatic Brain Injury
  • Felipe Jain, MD | Impact of Mentalizing Imagery Therapy on family dementia caregivers with suicidal ideation: feasibility and diffusion tensor imaging measures
  • Albert Yeung, Md, ScD An introduction to Ketamine Assisted Psychotherapy (KAP) 

S22. Nutritional Psychiatry Session

  • Wolfgang Marx, PhD (Chair) | Nutrition in Mental Health: Current Trends and Updates
  • Annabel S. Mueller-Stierlin, PhD | Subjective implications of dietary intake and eating behaviours for people with serious mental illness
  • Jane Chang, MD, PhD | Omega-3 PUFAs in Children and Adolescents: Focused on ADHD, ASD and Depression
  • Calogero Longhitano, MD | Rationale for the use of Ketogenic diet and in Bipolar Affective Disorder and Schizophrenia: the current clinical evidence and a proposed RCT.
  • Angela Sherwin, BSc | HAPI Trial – High Anxiety Pyrrole Intervention Trial

S23. Effects of Ketogenic Diet Therapy Session

  • Calogero Longhitano, PhD (Chair) | Nutritional interventions in psychosis review. A brief history of dietary interventions in severe mental disorders and how a low-carb high-fat diet can act as a powerful metabolic enhancer of brain cell function. 
  • Zoltan Sarnyai, PhD | From Mice to Men. Effects of ketogenic diet on behavioural models of psychiatry and why the effect might be translatable to humans. 
  • Christopher Palmer, MD | Ketogenic Diet in psychosis, mitochondrial health and a new paradigm to explain mental disorders